Celgene Corp (CELG)

CELG (NASDAQ:Drugs)
$115.17
pos +2.40
+2.10%
Today's Range: 114.63 - 116.20 | CELG Avg Daily Volume: 5,114,500
Last Update: 12/18/14 - 11:28 AM EST
Volume: 1,997,707
YTD Performance: 33.54%
Open: $115.20
Previous Close: $112.82
52 Week Range: $66.85 - $119.84
Oustanding Shares: 798,704,188
Market Cap: 87,929,344,057
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 16 16 16
Moderate Buy 1 1 1 1
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.26 1.26 1.26 1.35
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 57.64
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
57.64 57.60 24.82
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
22.28% 40.33% 254.28%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.87 $n.a. $3.26 $4.50
Number of Analysts 3 0 2 3
High Estimate $0.88 $n.a. $3.26 $4.94
Low Estimate $0.85 $n.a. $3.26 $4.27
Prior Year $0.67 $0.73 $2.68 $3.26
Growth Rate (Year over Year) 30.83% n.a.% 21.64% 38.14%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Timothy Collins

 | Dec 16, 2014 | 3:48 PM EST

Why I'm looking at the iShares Biotech ETF and Amgen.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

By

Jim Cramer

 | Dec 3, 2014 | 3:59 PM EST

An immense market rotation is happening.

By

Jim Cramer

 | Dec 2, 2014 | 2:23 PM EST

The end-of-the-year phenomenon is working.

By

Jim Cramer

 | Dec 2, 2014 | 11:38 AM EST

In this era of turmoil, investors can take comfort in this sector.

By

Robert Lang

 | Nov 25, 2014 | 10:00 AM EST

Selling option premium into Thanksgiving can be a lucrative strategy.

By

Jim Cramer

 | Nov 24, 2014 | 4:12 PM EST

This market provides a slew of reasons to buy right now.

By

Jim Cramer

 | Nov 21, 2014 | 1:12 PM EST

Don't get too excited bidding CMI and CAT.

By

Jim Cramer

 | Nov 18, 2014 | 4:04 PM EST

In this market, negativity is rarely being rewarded.

By

Jim Cramer

 | Nov 11, 2014 | 4:13 PM EST

Investors are seeing growth today in three areas.

If AAPL is going to continue to rally....this cluster zone and prior swing high need to be...
Yesterday and today was the classic case of watching realized vol. in the SPX and other in...
I had the chance to talk at length with Whole Foods co-CEO Walter Robb yesterday for a pie...
When the market gives your a chance to take profits, you TAKE IT! Today is that day, and ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.